UNITED NATIONS NATIONS UNIES
W O R L D H E A L T H O R G A N I Z A T I O N
ORGANISATION MONDIALE DE LA SANTÉ
EXECUTIVE ВОАПБ E B 1 V 5 7
7 January 1953 Eleventh Session
OPJGINiLL; ENGLISH
. APPLICATION F O R ?ULL APPROVAL BY ШЮ 0? THE YELLOTi^EVER feGGIIÎE PRODUCED 31 THE
ШСПЬИОЫЕ a ^ S m R G H IA30ÎUIT0RIE3 at ВЕСКЕШШ1, KENT (UK)
The reasons underlying the submission of this application are as follows:
On 9 December 1944 the ШША. Expert Gonraission on Quarantine recommended that, while, certain yellow-iever vaccines should be fully approved for the'
purposes of the issue of International Certificates of Vaccination against Yellow F e v e r , certain vaccines, namely those produced by the Yellow Fever Laboratories in Bogota and Rio de Janeiro, and by the Vi'ellóome Laboratories, London, should, because the drying of the vaccine was not. carried out to an adequate degree, be accorded only partial approval.
The Executive Board, at its fifth session, gave full approval to the yellow- 1
fever vaccina produced at the Laboratories in Bogota and Rio d e Janeiro.
On 29 October 1952, a request was received from the Director of the tiellcome Research Lr.borator^os, Вескеп1гал, Г or consideration to "be {jiven Ъу '.ШО for full approval of the j'-ello.v-fever vaccine propared by his laboratories. In support of his application a statement 窗 made tliat the apparatus now used for drying is completely n e — , c.nd a protocol vr^s enclosed giving the results 01 "water content"
and titres of six batches of the vaccine lc.pt at 4 ° G for six months.
？ollonin¿‘ the established practice, the Director-General forwarded all relevant data to those members of the Expert Panel on Yellow Fever concerned
with the evaluation of yellow-fever vaccines, viz., Drs. C . Durieux, A.F'. Mahaffy, r.M, Taylor and M.V. Veldee, and invited their recommendations as to whether or not the vaccine prepared by the Viellcome iieaearch Laboratories, Beclcenhsua, should, in the li-ht of the information provided, be accorded full recognition by 1Ш0.
^ f f . R e c . World Hlth O r g . 2 5 , p.5, item 2*1.4.2
EBll/57 • page 2
The Panel members consulted were unanimous in recommending that full approval be given by 1Ш0 in respect of this vaccine.
The Executive Board may wish to take a resolution according full approval, for the purposes of the issue of international certificates, to the yellow-fever vaccine produced by the Wellcome Research Laboratories, Beckenham.
